AAN: Gene Therapy Puzzling in Diabetic Neuropathy
SEATTLE (MedPage Today) — Patients with diabetic polyneuropathy benefited from an investigational gene therapy, but not in the way researchers expected.
Similar Posts on depression:
- AAN: Gene Therapy Puzzling in Diabetic Neuropathy Trial
- AAN: Tramiprosate Ineffective in Alzheimer’s Disease
- AAN: Stormy Weather Worsens Sleep Apnea
- Hypoglycemic Episodes Hike Risk of Dementia in Older Diabetics
- APA: Inhaled Agent Loxapine Effective in Acute Agitation (CME/CE)
- AAN: Epilepsy Drug Not Effective for Chronic Headache
- AAN: Diet Linked to Alzheimer’s Risk
- AAN: Nimble Activity Protects Against Mild Cognitive Impairment
- FDA Review Questions Cardiac, Suicide Risks for Investigational Antipsychotic
- Study May Ease Some Concerns About Smoking-Cessation Drug
